Downregulated NF-κB further contributes to reduce the secretion of IL-6, TGF-β1, VEGF, and IL-17A in tumor cell and increase the level of regulatory T cells that collectively inhibits the progression of epithelial ovarian cancer (308). Here, NFKB1 is linked to ovarian carcinoma.